Exclusive: Mylan chairman says Teva offers nothing we can't do on our own

Teva Pharmaceutical Industries Ltd.’s $40 billion offer for generic drug giant Mylan N.V. was intended as a diversion to Mylan’s bid for Irish pharmacy product company Perrigo Co...